Highly Active Antiretroviral Therapy
- 1 January 2001
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 19 (7), 709-713
- https://doi.org/10.2165/00019053-200119070-00001
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Economic Analysis of Initial HIV TreatmentPharmacoEconomics, 2001
- Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapyAIDS, 1999
- Cost effectiveness of highly active antiretroviral therapy in HIV-infected patientsAIDS, 1999
- Costs of HIV medical care in the era of highly active antiretroviral therapyAIDS, 1999
- Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical TrialAIDS Research and Human Retroviruses, 1999
- Decreased Medical Expenditures for Care of HIV-Seropositive PatientsPharmacoEconomics, 1999
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997
- Cost-effectiveness ratios: in a league of their ownHealth Policy, 1994
- Discounting in the Economic Evaluation of Health Care InterventionsMedical Care, 1993
- Cost effectiveness/utility analyses: Do current decision rules lead us to where we want to be?Journal of Health Economics, 1992